Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

Delayed Quote. Delayed  - 02/10 03:59:50 pm
6.54 USD   +2.19%
02/04 OSIRIS THERAPEU : CEO Debrabandere resigns
02/03 OSIRIS THERAPEU : Announces Leadership Transition
02/02 OSIRIS THERAPEU : Announces 100% Medicare Coverage for Grafix
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
6.06(c) 6.39(c) 6.23(c) 6.4(c) 6.535(c) Last
386 860 146 238 120 416 111 995 106 844 Volume
-13.30% +5.45% -2.50% +2.73% +2.11% Change
More quotes
Financials ($)
Sales 2015 94,9 M
EBIT 2015 4,40 M
Net income 2015 2,77 M
Debt 2015 -
Yield 2015 -
Sales 2016 110 M
EBIT 2016 5,03 M
Net income 2016 4,54 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 80,00
P/E ratio 2016 51,20
Capi. / Sales 2015 2,32x
Capi. / Sales 2016 2,00x
Capitalization 220 M
More Financials
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The Therapeutics... 
More about the company
Surperformance© ratings of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on OSIRIS THERAPEUTICS, INC.
02/04 OSIRIS THERAPEUTICS : CEO Debrabandere resigns
02/03 OSIRIS THERAPEUTICS : Change in Directors or Principal Officers, Financial State..
02/03 OSIRIS THERAPEUTICS : Announces Leadership Transition
02/02 OSIRIS THERAPEUTICS : Announces 100% Medicare Coverage for Grafix
01/23 OSIRIS THERAPEUTICS : counters report questioning sales
01/21 OSIRIS THERAPEUTICS : DEADLINE TOMORROW: Levi & Korsinsky, LLP Notifies Sharehol..
01/20 OSIRIS THERAPEUTICS : Bragar Eagel & Squire, P.C. : Announces That a Class Actio..
01/20 OSIRIS THERAPEUTICS : 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; For..
More news
Sector news : Bio Therapeutic Drugs
11:38a LONZA : and Renova Therapeutics Announce Manufacturing Agreement for Clinical Su..
05:04a PFIZER : Commends The FDA Advisory Committee's Vote To Approve Proposed Biosimil..
02/09DJPanel Recommends FDA Approval of Remicade Knockoff
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
02/05 Osiris chief exit reinforces problems at company
02/03 Osiris chief bids adieu
01/15 Microsoft's Big New Move In Mobile Ads
01/15 OSIRIS : Aggressive Channel Stuffing, Accounting Irregularities Or Outright Frau..
2015 The Resignation Of Osiris Therapeutics' Auditor Really Opens The Door For Mor..


Comments 
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions